… This article focuses on the care of the patient with newly diagnosed ovarian cancer. …
diagnostic imaging in higher-risk patients currently represent the only approach for ovarian cancer …

… ovarian cancer … in ovarian cancer, as it is used not only for diagnosis and staging but also
therapeutically, even in patients with widely disseminated, advanced disease. Ovarian cancer …

… The proper treatment of early ovarian cancer involves resection of the primary tumor … ovarian
cancer in FIGO stage I to IIA (except stage IA, G1). For women with advanced ovarian cancer…

… ], [39], [40], [41], [42], [43], [44], [45], [46], [47], [48], [49], [50], [51], [52], [53]], in the current work,
we reviewed different nanomaterials applied to diagnosis and treatment of ovarian cancer. …

… is epithelial ovarian cancer. The significant risk factor for development of ovarian cancer is
… with the BRCA1 and BRCA2 genes—in at least 5% to 10% of all epithelial ovarian cancers. …

… cancer associated antibodies and radiolabeled antibody conjugates are forming the basis for
early diagnosis of ovarian cancer… role of immune system against ovarian cancer. This high …

… ovarian cancer. Nanomaterial biosensor-based tumor markers and their various types for
ovarian cancer diagnosis … the ovarian cancer therapy have also been underpinned. To ensure …

… Ovarian cancer is the eighth most common female cancer … About 220,000 women are
diagnosed with ovarian cancer each … use of miRNAs in diagnosis and treatment of ovarian cancer. …

… What treatments are available for ovarian cancer? The mainstay of treating ovarian cancer
is a combination of surgery and chemotherapy—the latter normally platinum based. The best …

… , most patients with advanced ovarian cancer ultimately develop … the diagnosis and treatment
of patients with ovarian cancer … in the molecular characterization of ovarian cancer and the …